Nanobiotix (NBTX) Retained Earnings: 2019-2025

  • Nanobiotix's Retained Earnings fell 26.38% to -$428.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$428.1 million, marking a year-over-year decrease of 26.38%. This contributed to the annual value of -$406.5 million for FY2024, which is 35.76% down from last year.
  • Latest data reveals that Nanobiotix reported Retained Earnings of -$428.1 million as of Q2 2025, which was down 5.32% from -$406.5 million recorded in Q4 2024.
  • Over the past 5 years, Nanobiotix's Retained Earnings peaked at -$209.9 million during Q4 2021, and registered a low of -$428.1 million during Q2 2025.
  • Over the past 3 years, Nanobiotix's median Retained Earnings value was -$338.8 million (recorded in 2024), while the average stood at -$355.9 million.
  • Data for Nanobiotix's Retained Earnings shows a maximum YoY plummeted of 36.48% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Nanobiotix's Retained Earnings stood at -$209.9 million in 2021, then dropped by 9.56% to -$244.5 million in 2022, then dropped by 26.04% to -$297.8 million in 2023, then crashed by 36.48% to -$406.5 million in 2024, then fell by 26.38% to -$428.1 million in 2025.
  • Its Retained Earnings stands at -$428.1 million for Q2 2025, versus -$406.5 million for Q4 2024 and -$338.8 million for Q2 2024.